Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 6/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KCNJ1 | P48048 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12379760 | 0.89 | NOTUM (0.53) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL2293966 | 0.84 | NOTUM (0.48) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL12379764 | 0.79 | ALDH1A1 (0.42) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL6244401 | 0.77 | NOTUM (0.50) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL29211840 | 0.75 | NOTUM (0.43) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL12615985 | 0.72 | NOTUM (0.78) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL20969938 | 0.71 | NOTUM (0.38) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL29710932 | 0.71 | NOTUM (0.39) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL20969940 | 0.71 | NOTUM (0.41) | NOTUMF2MAPTALDH1A1KCNJ1 | |
| SCHEMBL12075564 | 0.70 | NOTUM (0.54) | NOTUMF2MAPTALDH1A1KCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090008002-A1 | Gas generant compositions | CBR3, CBR1, NOX5 | NOTUM 2783/4885F2 1312/4885MAPT 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.